USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -42.13 Thousand | 7373.00 |
Net Income | - | - | - | - | -385.89 Thousand | -351.09 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 288.91 Thousand | 366.98 Thousand |
Other non-cash items | - | - | - | - | 54.84 Thousand | -90.13 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 42.53 Thousand | -7397.00 |
Debt repayment | - | - | - | - | -42.53 Thousand | -7397.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | -14.90 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | 81.62 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 288.91 Thousand | 285.36 Thousand |
Cash at beginning of period | - | - | - | 405.00 | 3.00 | 0.03 |
Cash at end of period | - | - | - | 405.00 | 405.00 | 3.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 402.00 | 2.97 |
Free Cash Flow | - | - | - | - | -42.13 Thousand | 7373.00 |
Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2019 Q1 | 2018 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -110.73 | -385.89 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 78.51 | 288.91 Thousand |
Other non-cash items | - | - | - | - | 26.81 | 54.84 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 7.00 | 42.53 Thousand |
Debt repayment | - | - | - | - | - | -42.53 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 7.00 | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 78.51 | 288.91 Thousand |
Cash at beginning of period | - | - | - | 405.00 | 0.41 | 3.00 |
Cash at end of period | - | - | - | 405.00 | 1.99 | 405.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 1.58 | 402.00 |
Free Cash Flow | - | - | - | - | -5.42 | -42.13 Thousand |
1610
AQN-PA
4240
ERIXF
7087
0037